Malignant Urinary System Neoplasm — Trials

Malignant Urinary System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,851 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 887
Recruiting: 467
Ph III recruiting: 52
Growth YoY: +12.2%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (556)

clinicaltrialsPublishedShowing 151–200 of 3,851 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07817173	Feasibility of HISA During TURBT for NMIBC	not yet recruiting	N/A	40	CAMC Health SystemOTHER	1	Sep 14, 2026	clinicaltrials
NCT05432232	The HistoSonics Investigational System for Treatment of Primary Solid Renal Tumors Using Histotripsy(CAIN)	completed	N/A	20	HistoSonics, Inc.INDUSTRY	1	Sep 11, 2026	clinicaltrials